"Carcinoembryonic Antigen Peptide 1-6D"^^ . . _:b654113 . "Carcinoembryonic Antigen Peptide 1-6DSYNCI" . "C2622"^^ . "Modified CEA PeptideSYNCI" . "Amino Acid, Peptide, or Protein"^^ . _:b654114 . "mCEA PeptideSYNCI" . "Carcinoembryonic Antigen Peptide 1-6DPTNCI" . . "C0935801"^^ . "HLA-A2 positive patients with CEA-producing adenocarcinomas of the gastrointestinal tract origin and refractory stage IV CEA-expressing malignancies."^^ . _:b654112 . _:b654113 . "CAP-1-6D PeptideABNCI" . _:b654113 . _:b654114 . _:b654115 . _:b654112 . "38236"^^ . _:b654114 . "701524"^^ . _:b654112 . _:b654115 . _:b654115 . "CEA:571-579 (576D)SYNCI" . "CEA_571-579_Peptide"^^ . "38236"^^ . _:b654112 . . _:b654115 . "Carcinoembryonic Antigen Peptide 1-6D"^^ . _:b654113 . "A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.NCI" . "Pharmacologic Substance"^^ . _:b654114 .